CATALOGO DEI PRODOTTI DELLA RICERCA

Fassio, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.247
EU - Europa 5.756
AS - Asia 4.572
SA - Sud America 666
Continente sconosciuto - Info sul continente non disponibili 282
AF - Africa 192
OC - Oceania 16
Totale 18.731
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.934
RU - Federazione Russa 2.606
SG - Singapore 1.828
CN - Cina 1.177
IT - Italia 804
GB - Regno Unito 666
BR - Brasile 523
DE - Germania 464
VN - Vietnam 404
HK - Hong Kong 388
SE - Svezia 266
FR - Francia 259
IE - Irlanda 258
CA - Canada 159
IN - India 155
KR - Corea 141
FI - Finlandia 130
BD - Bangladesh 117
JP - Giappone 83
NL - Olanda 60
AR - Argentina 56
MX - Messico 46
ID - Indonesia 44
UA - Ucraina 43
PL - Polonia 41
TR - Turchia 36
ZA - Sudafrica 36
NG - Nigeria 34
ES - Italia 33
TG - Togo 27
IQ - Iraq 25
BJ - Benin 24
CR - Costa Rica 23
PK - Pakistan 23
CO - Colombia 22
EG - Egitto 22
AT - Austria 21
UZ - Uzbekistan 19
VE - Venezuela 17
EC - Ecuador 16
RO - Romania 16
PH - Filippine 14
SA - Arabia Saudita 14
BE - Belgio 13
HN - Honduras 12
IR - Iran 12
LT - Lituania 12
AU - Australia 11
CH - Svizzera 11
CW - ???statistics.table.value.countryCode.CW??? 11
GT - Guatemala 11
IL - Israele 11
PR - Porto Rico 11
JM - Giamaica 10
SV - El Salvador 10
CL - Cile 9
MA - Marocco 9
NI - Nicaragua 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
MY - Malesia 8
PT - Portogallo 8
AM - Armenia 7
ET - Etiopia 7
PE - Perù 7
QA - Qatar 7
TT - Trinidad e Tobago 7
CZ - Repubblica Ceca 6
NP - Nepal 6
SC - Seychelles 6
AZ - Azerbaigian 5
DK - Danimarca 5
GR - Grecia 5
HR - Croazia 5
KE - Kenya 5
KW - Kuwait 5
AL - Albania 4
BO - Bolivia 4
LB - Libano 4
PY - Paraguay 4
TN - Tunisia 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
GE - Georgia 3
GP - Guadalupe 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
SI - Slovenia 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BS - Bahamas 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EE - Estonia 2
KH - Cambogia 2
KZ - Kazakistan 2
Totale 18.421
Salva come PNG Salva come JPEG
Città #
Ashburn 1.079
Moscow 984
Singapore 984
Dallas 789
San Jose 778
Chandler 609
Southend 484
Hong Kong 365
Council Bluffs 289
Dublin 253
Verona 221
Beijing 217
New York 167
The Dalles 166
Los Angeles 160
Jacksonville 134
Ho Chi Minh City 131
Redmond 97
Santa Clara 97
Princeton 85
Lawrence 83
Wilmington 80
Tokyo 79
Hanoi 75
Helsinki 75
Houston 71
Munich 70
Ann Arbor 62
Buffalo 62
Jinan 61
Shenyang 57
Milan 53
Redondo Beach 53
São Paulo 53
Woodbridge 52
Bologna 51
Orem 51
London 48
Nanjing 46
Rome 45
San Francisco 45
Tianjin 45
Chicago 40
Sindelfingen 39
Montreal 38
Hyderabad 36
Phoenix 35
Columbus 34
Hebei 34
Washington 34
Warsaw 33
Abuja 32
Zhengzhou 32
Atlanta 31
Denver 31
Falkenstein 31
Turku 31
Toronto 29
Hangzhou 28
Haikou 27
Lomé 27
Changsha 25
Seattle 25
Cotonou 24
Boston 23
Brooklyn 23
Amsterdam 22
Da Nang 22
Johannesburg 21
Guangzhou 20
Jakarta 20
Ningbo 20
San José 19
Tashkent 19
Chennai 18
Frankfurt am Main 18
Manchester 18
Poplar 18
Mexico City 17
Naples 17
Stockholm 17
Fairfield 15
Jiaxing 15
McKinney 15
Mumbai 15
Nanchang 15
Redwood City 15
Seoul 15
Taiyuan 15
Taizhou 15
Biên Hòa 14
Haiphong 14
Rio de Janeiro 14
Annandale 13
Dong Ket 13
North Bergen 13
Brussels 12
Cleveland 12
Shenzhen 12
Belo Horizonte 11
Totale 10.697
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 362
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 299
Anti-CCP antibodies and bone 253
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 248
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 241
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 227
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 221
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 219
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 218
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 216
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 210
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 208
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 206
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 201
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 199
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 199
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 194
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 193
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 190
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 187
The obesity paradox and osteoporosis 185
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 184
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 184
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 182
Association between environmental air pollution and rheumatoid arthritis flares 179
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 176
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 174
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 173
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 172
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 171
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 171
Association between acute exposure to environmental air pollution and fragility hip fractures 168
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 168
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 167
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 167
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 166
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 164
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 164
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes 163
Periostin: The bone and beyond 163
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 160
Calcium and vitamin D supplementation: when and why 160
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy 159
Drug-induced osteonecrosis of the jaw: the state of the art 157
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 156
Changes in bone turnover markers and bone modulators during abatacept treatment 152
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 152
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 151
Bone Geometry, Quality, and Bone Markers in Children with Type 1 Diabetes Mellitus 151
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 151
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 151
Rheumatoid arthritis, γδ T cells and bisphosphonates 149
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 148
Effects of secukinumab on serum adipocytokines: preliminary data 147
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 147
Insight into the WNT system and its drug related response. 146
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 146
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 145
Duration of treatment for osteoporosis 144
Correction to: The obesity paradox and osteoporosis 143
Osteoporosis in Rheumatic Diseases 143
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 142
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis 142
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis Medications 141
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 141
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 141
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 140
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 139
Wnt pathway involvement and its response to treatment in the development of bone damage in different inflammatory and non-inflammatory rheumatic contidions 139
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 135
Bone health status evaluation in men by means of REMS technology 133
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 133
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 133
Vitamin D: not just bone, but also immunity 132
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 132
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 131
Radiological features of knee joint synovial chondromatosis 130
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 129
Vitamin D and Osteogenesis Imperfecta in Pediatrics 127
Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) 125
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 123
Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study 123
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 123
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 123
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 122
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 121
Pharmacological management of osteoporosis in postmenopausal women: The current state of the art 121
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 121
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 120
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 119
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 116
Ultrasonographic detection, definition and quantification of soft tissue oedema in psoriatic dactylitis 116
Nail ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review 113
Long-Term Bone Mineral Density Changes in Kidney Transplant Recipients Treated with Denosumab: A Retrospective Study with Nonequivalent Control Group 112
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 112
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 108
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 107
Machine learning to characterize bone biomarkers profile in rheumatoid arthritis 105
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 105
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 104
Totale 15.969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.375
article - articoli 68.594
book - libri 0
conference - conferenze 715
curatela - curatele 0
other - altro 928
patent - brevetti 0
selected - selezionate 0
volume - volumi 138
Totale 140.750
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022411 0 0 0 0 23 23 19 31 54 24 36 201
2022/20231.724 98 175 142 329 157 400 17 87 206 28 66 19
2023/20241.120 37 89 101 124 110 220 60 59 30 63 171 56
2024/20252.695 114 127 126 450 164 88 127 111 391 278 242 477
2025/20268.871 552 446 686 1.486 2.300 557 820 500 611 454 184 275
2026/20271.645 150 211 276 966 42 0 0 0 0 0 0 0
Totale 18.731